Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B With Poor Response to Other Drugs
NCT01475851
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
34
Enrollment
INDUSTRY
Sponsor class
Conditions
Hepatitis B, Chronic
Interventions
DRUG:
GSK548470 300 mg tablet
Sponsor
GlaxoSmithKline